KIMIA BIOSCIENCES
|
KIMIA BIOSCIENCES Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -1.98 | -0.78 | 1.08 | 0.30 | 2.64 |
| CEPS(Rs) | -1.27 | -0.16 | 1.48 | 0.66 | 3.39 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 1.15 | 3.15 | 3.90 | 2.86 | 2.39 |
| Tax Rate(%) | 24.51 | 26.21 | 7.77 | -12.63 | -1.30 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -3.96 | 0.51 | 6.31 | 4.19 | 5.93 |
| EBIT Margin(%) | -6.34 | -1.10 | 6.72 | 3.53 | 6.18 |
| Pre Tax Margin(%) | -9.64 | -4.02 | 4.17 | 1.15 | 4.05 |
| PAT Margin (%) | -7.28 | -2.96 | 3.85 | 1.30 | 4.10 |
| Cash Profit Margin (%) | -4.68 | -0.61 | 5.29 | 2.86 | 5.27 |
| Performance Ratios | |||||
| ROA(%) | -8.28 | -3.44 | 5.31 | 1.83 | 6.24 |
| ROE(%) | -91.91 | -22.22 | 32.19 | 16.47 | 243.83 |
| ROCE(%) | -14.30 | -2.32 | 16.13 | 8.94 | 16.94 |
| Asset Turnover(x) | 1.14 | 1.16 | 1.38 | 1.41 | 1.52 |
| Sales/Fixed Asset(x) | 2.85 | 3.18 | 4.68 | 5.13 | 5.55 |
| Working Capital/Sales(x) | 20.24 | 11.08 | 6.92 | 4.76 | 5.49 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.35 | 0.31 | 0.21 | 0.19 | 0.18 |
| Receivable days | 86.33 | 105.16 | 108.76 | 114.09 | 113.91 |
| Inventory Days | 121.06 | 88.70 | 60.51 | 62.52 | 49.92 |
| Payable days | 164.94 | 140.43 | 108.06 | 100.58 | 95.41 |
| Valuation Parameters | |||||
| PER(x) | - | - | 35.18 | 67.14 | 13.46 |
| PCE(x) | -25.54 | -233.46 | 25.60 | 30.49 | 10.47 |
| Price/Book(x) | 28.15 | 11.95 | 9.74 | 6.98 | 14.86 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.60 | 1.75 | 1.68 | 1.19 | 0.87 |
| EV/Core EBITDA(x) | -54.80 | 139.42 | 20.56 | 23.26 | 11.87 |
| EV/EBIT(x) | -25.32 | -158.27 | 24.97 | 33.54 | 14.11 |
| EV/CE(x) | 1.76 | 2.01 | 2.09 | 1.47 | 1.25 |
| M Cap / Sales | 1.20 | 1.42 | 1.35 | 0.87 | 0.55 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 2.89 | -5.89 | 24.86 | 13.17 | 23.08 |
| Core EBITDA Growth(%) | -340.65 | -85.57 | 100.09 | -21.52 | 107.29 |
| EBIT Growth(%) | -491.19 | -115.43 | 137.67 | -35.28 | 165.46 |
| PAT Growth(%) | -152.56 | -172.55 | 269.62 | -64.18 | 131.48 |
| EPS Growth(%) | -152.56 | -172.55 | 262.15 | -88.72 | 131.48 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 9.69 | 2.73 | 2.44 | 2.54 | 7.39 |
| Current Ratio(x) | 1.08 | 1.18 | 1.38 | 1.58 | 1.56 |
| Quick Ratio(x) | 0.45 | 0.58 | 0.91 | 1.05 | 1.03 |
| Interest Cover(x) | -1.92 | -0.38 | 2.63 | 1.48 | 2.91 |
| Total Debt/Mcap(x) | 0.34 | 0.23 | 0.25 | 0.37 | 0.59 |
Compare Financial Ratios of peers of KIMIA BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KIMIA BIOSCIENCES | ₹244.1 Cr | -5% | -4% | 46.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
| CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics | |
KIMIA BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KIMIA BIOSCIENCES | -5% |
-4% |
46.5% |
| SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses
